RBC
CLX icon

Roble Belko & Company’s Clorox CLX Stock Holding History

Roble Belko & Company’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$124K Buy
1,302
+15
+1% +$1.44K 0.01% 159
2026
Q1 		$133K Buy
1,287
+12
+0.9% +$1.36K 0.02% 158
2025
Q4 		$129K Buy
1,275
+508
+66% +$55.2K 0.02% 151
2025
Q3 		$95K Buy
767
+204
+36% +$25.3K 0.01% 145
2025
Q2 		$68K Buy
563
+202
+56% +$26.9K 0.01% 161
2025
Q1 		$53K Buy
361
+211
+141% +$32.2K 0.01% 163
2024
Q4 		$24K Buy
+150
New +$24.5K ﹤0.01% 205

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Roble Belko & Company's CLX Position: Q2 2026 in Review

Roble Belko & Company increased its Clorox (CLX) stake by 1.2% in Q2 2026, buying an estimated $1.44K and bringing the position to 1,302 shares worth $124K. The position accounts for 0.01% of the portfolio, ranked #159.

Roble Belko & Company first reported a position in CLX in Q4 2024 and has held it in 7 quarters since. The position peaked at $133K in Q1 2026. 1,055 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Roble Belko & Company held 1,302 shares of Clorox worth $124K as of Q2 2026.
  • Roble Belko & Company bought 15 Clorox shares in Q2 2026, an estimated $1.44K.
  • Clorox made up 0.01% of Roble Belko & Company's portfolio in Q2 2026, its #159 holding.
  • Roble Belko & Company first reported a position in Clorox in Q4 2024 and has held it in 7 quarters since.
  • Roble Belko & Company's Clorox position peaked at $133K in Q1 2026.
  • 1,055 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Roble Belko & Company's 13F filing for Q2 2026, filed 24 Jul 2026.